Assessment of in Vitro Comparative Dissolution Kinetics of Moxonidine Products as a Factor Potentially Determining Effectiveness of Antihypertensive Treatment
Aim. Investigation of comparative dissolution kinetics of generic medicinal products containing moxonidine versus reference drug. Material and methods. Objects of the research were film-coated tablets containing moxonidine (INN) in a dose 0.4 mg: a reference drug Physiotens® and 4 generic drugs. In...
Saved in:
Main Authors: | G. V. Ramenskaya, I. E. Shokhin, N. I. Gaponova, V. R. Abdrakhmanov |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2019-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1813 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MODERN APPROACHES OF DISSOLUTION PROFILE TEST (REVIEW)
by: D. Yu. Grebenkin, et al.
Published: (2019-01-01) -
RETROSPECTIVE OF DISSOLUTION TEST OF SOLID DOSAGE FORMS (REVIEW)
by: D. Yu. Grebenkin, et al.
Published: (2019-01-01) -
COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01) -
Moxonidine-based combination antihypertensive therapy in patients with metabolic syndrome
by: E. V. Tishina, et al.
Published: (2012-06-01) -
ADDITIONAL BENEFITS OF ANTIHYPERTENSIVE MOXONIDINE THERAPY IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION
by: E. N. Dudinskaya, et al.
Published: (2014-02-01)